Daytrana — Class II drug recall D-1169-2022
Ongoing recall by Noven Pharmaceuticals Inc, reported 2022-07-06, distributed nationwide. Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfe
| Recall number | D-1169-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Noven Pharmaceuticals Inc, Miami, FL, United States |
| Recall initiated | 2022-06-24 |
| Classified | 2022-06-29 |
| Reported by FDA | 2022-07-06 |
| Distributed | Nationwide (US) |
| Quantity | 8,559 cartons |
| NDC | 68968-5552, 68968-5552-03, 68968-5553, 68968-5553-03, 68968-5554, 68968-5554-03, 68968-5555, 68968-5555-03 |
| Lot numbers | 12/22, 91272 |
Product
Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 33186. NDC 68968-5552-3
Reason for recall
Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1169-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.